gvtcx

UK Research and Innovation - Oligonucleotide Synthesis and Nucleic Acid Sequencing Services Framework

UK Research and Innovation Published 25 Jun 2024 Find a Tender
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£8,000,000
Statuscomplete
Category (CPV) 73000000 +2 more
Deadline23 Oct 2023
Procedureopen
OCIDocds-h6vhtk-03f0a6

Awards (12)

This procurement was awarded to 12 suppliers. Values shown are per-award; the notice total is £8,000,000.

SupplierValueDateStatus
CeGat GmbH shared · · active
Edingburgh Genetics Limited shared · · active
Eurofins Genomics UK Ltd shared · · active
Eurogentec Ltd shared · · active
Genewiz UK Ltd shared · · active
IDT DNA shared · · active
Life Technologies Limited shared · · active
Macrogen Europe shared · · active
Merck Life Science UK Limited shared · · active
Randox Laboratories Ltd shared · · active
Source Bioscience UK Ltd shared · · active
Twist Bioscience shared · · active

description

***This is an Award Notice, Not a Call for Competition****

This Framework has been established for the provision of UK Research and Innovation: Oligonucleotide Synthesis and Nucleic Acid Sequencing Services .

This Framework is being Established for a term of 3 years + 1 year

notice history

3 notices published against this procurement.

PublishedTypeRegimeNotice
17 Aug 2023 Prior information notice (F01) Earlier regulations 024176-2023
15 Sept 2023 Contract notice (F02) Earlier regulations 027372-2023
25 Jun 2024 Contract award notice (F03) Earlier regulations 019387-2024

more from UK Research and Innovation

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.